Clinical Trial Update: Study the Safety and Efficacy of PTK 0796 in Patients With Complicated Skin and Skin Structure Infection (CSSSI) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating PTK 0796 for complicated skin and skin structure infections was terminated, with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complicated Skin and Skin Structure Infection

Drugs mentioned

• PTK 0796 (PTK 0796)

Snippet

Sponsor: Paratek Pharmaceuticals Inc | Conditions: Skin Diseases, Infectious | Phase 3 | Status: TERMINATED | Results posted: 2021-03-12